Industry News
OTUD7B Protects Enzyme That Controls Pathway Tied To Autoimmune Disease, Cancer
Jan 24, 2013
Marked for death with molecular tags that act like a homing signal for a cell's protein-destroying machinery, a pivotal enzyme is rescued by another molecule that sweeps the telltale targets off in the nick of time. The enzyme, called TRAF3, lives on to control a molecular network that's implicated in a variety of immune system-related diseases if left to its own devices... Read More
New Advances For GI Cancers Revealed At 2013 Gastrointestinal Cancers Symposium
Jan 24, 2013
New research into the treatment and prognosis of gastrointestinal cancers was released in advance of the tenth annual Gastrointestinal Cancers Symposium being held January 24-26, 2013, at The Moscone West Building in San Francisco, CA... Read More
Medulloblastoma Spurred On By Oxygen-Free Energy Designed To Fuel Brain Development
Jan 24, 2013
The metabolic process which fuels the growth of many cancers has its origins in normal brain growth finds a new study published in BioMed Central's open access journal Cancer & Metabolism... Read More
Fighting Triple-Negative Breast Cancer With The Help Of Vitamin D
Jan 24, 2013
In research published in The Journal of Cell Biology, a team led by Susana Gonzalo, Ph.D., assistant professor of biochemistry and molecular biology at Saint Louis University, has discovered a molecular pathway that contributes to triple-negative breast cancer, an often deadly and treatment resistant form of cancer that tends to strike younger women... Read More
New Drug Target For Her-2 Related Breast Cancer
Jan 24, 2013
Research led by Dr. Suresh Alahari, the Fred Brazda Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans and its Stanley S. Scott Cancer Center, details exactly how the Her2 cancer gene promotes the progression and spread of breast cancer cells. The inactivation of a tumor suppression gene called Nischarin is among the mechanisms identified... Read More
Prostate Cancer Diagnoses Up, Deaths Down, Latest UK Figures
Jan 23, 2013
1 in 7 boys born in 2015 will be diagnosed with prostate cancer during his lifetime, compared with 1 in 20 in 1990, according to the latest figures from Cancer Research UK, who suggest the main reason is the increased use of the PSA test, plus the fact men are living longer... Read More
New Drug Protects Against Side Effects Of Chemotherapy
Jan 23, 2013
A drug developed at Linkoping University in Sweden protects against the side effects of cancer treatments while strengthening the effects on the tumour. An international drug evaluation is now starting up on a larger group of patients... Read More
Life Expectancy Reduced In Schizophrenia Patients
Jan 23, 2013
A new study from Lund University in Sweden shows that the average life expectancy of men and women with schizophrenia is 15 years and 12 years shorter respectively than for those who do not suffer from the disease. The study has been carried out in collaboration with Stanford University in the US... Read More
Tumor 'Separation Surgery' And High-Dose Stereotactic Radiosurgery To Control Spine Metastases
Jan 23, 2013
Researchers from Memorial Sloan-Kettering Cancer Center (New York, NY) have found that tumor "separation surgery" followed by high-dose hypofractionated stereotactic radiosurgery (SRS) or high-dose single-fraction SRS is safe and effective in controlling spinal metastases regardless of the radiosensitivity of the particular tumor type that has invaded the spine... Read More
Cholesterol Finding Offers New Way To Kill Lymphoma Without Chemotherapy
Jan 23, 2013
How do you annihilate lymphoma without using any drugs? Starve it to death by depriving it of what appears to be a favorite food: HDL cholesterol. Northwestern Medicine® researchers discovered this with a new nanoparticle that acts like a secret double agent. It appears to the cancerous lymphoma cell like a preferred meal -- natural HDL... Read More
Previous Page Next Page